FDA Public Workshop Development of Safe and Effective Drug Therapies for CFS and ME Speaker, Panelist and Moderator Disclosure Form April 25 and 26, 2013 Dear Speaker, Panelist or Moderator: Please complete this form reg - Hemispherx Biopharma - Document - PDFSEARCH.IO

First Page	Meta Content
	FDA Public Workshop Development of Safe and Effective Drug Therapies for CFS and ME Speaker, Panelist and Moderator Disclosure Form April 25 and 26, 2013 Dear Speaker, Panelist or Moderator: Please complete this form reg Add to Reading List Open Document File Size: 17,48 KB Share Result on Facebook City Bethesda / / / IndustryTerm pharmaceutical / drug products / Therapies for Chronic Fatigue Syndrome / / MedicalCondition Myalgic Encephalomyelitis / Chronic Fatigue Syndrome / / Organization FDA / / Person Robert Miller / Moderator Disclosure Form April / Robert D. Miller / Mary Gross / Panelist / / Position advocate / Speaker / ME Speaker / / ProvinceOrState Maryland / / SocialTag Antivirals Rintatolimod Chronic fatigue syndrome Hemispherx Biopharma Encephalomyelitis Myelitis Me Myalgia Pharmaceutical industry Health

FDA Public Workshop Development of Safe and Effective Drug Therapies for CFS and ME Speaker, Panelist and Moderator Disclosure Form April 25 and 26, 2013 Dear Speaker, Panelist or Moderator: Please complete this form regAdd to Reading List